Skip to content

EBITDA margin at other companies

AdaptHealth logo
AdaptHealthAHCO
12.7%-5.9pp
Evolent Health, Inc. logo
Evolent Health, Inc.EVH
-16.2%-19.7pp
The Pennant Group, Inc. logo
The Pennant Group, Inc.PNTG
6.4%-0.1pp
ResMed logo
ResMedRMD
38.2%+2.5pp
UFP Technologies logo
UFP TechnologiesUFPT
19.2%+0.1pp
Merit Medical Systems logo
Merit Medical SystemsMMSI
20.2%+0.9pp

Other financials

Income statement

See full
Revenue$75.4M+27.5%
Gross profit$42.8M+28.7%
Operating income$4.3M+11.8%
Net income$2.6M-1.6%
EPS (diluted)$0.060.0%

Balance sheet

See full
Cash & equivalents$9.8M-3.9%
Total debt$12.4M+84.0%
Total equity$143.9M+6.8%
Total assets$197.4M+10.8%

Cash flow

See full
Operating cash flow$8.1M+183%
CapEx$6.7M-56.6%
Free cash flow$1.4M+111%

Valuation

See full
Market cap$448.16M+71.3%
Enterprise value$450.83M+74.6%
P/E30.1×+8.8×
P/S1.6×+0.4×

Profitability

See full
Gross margin57.6%-1.1pp
Operating margin8.2%-0.2pp
Net margin5.2%-0.1pp
FCF margin9%

Returns & leverage

See full
Return on equity10.7%+0.9pp
Debt / equity0.1×0.0×
Current ratio1.2×-0.2×

Where this comes from

Calculated from Viemed Healthcare, Inc.’s reported figures.

Based on trailing twelve months.

The official record: Viemed Healthcare, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Viemed Healthcare, Inc.'s ebitda margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Viemed Healthcare, Inc.'s EBITDA margin?
Viemed Healthcare, Inc. (VMD) reported EBITDA margin of 18.5% in Q1 2026.
How has Viemed Healthcare, Inc.'s EBITDA margin changed year-over-year?
Viemed Healthcare, Inc.'s EBITDA margin decreased by 4.8% year-over-year, from 19.4% to 18.5%.
What is the long-term trend for Viemed Healthcare, Inc.'s EBITDA margin?
Over 5 years (2020 to 2025), Viemed Healthcare, Inc.'s EBITDA margin has grown at a -7.2% compound annual growth rate (CAGR), from 27.7% to 19.1%.
What does EBITDA margin mean?
EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.